Document Detail

Efficacy and safety of cholesterol-lowering treatment.
MedLine Citation:
PMID:  16473116     Owner:  NLM     Status:  MEDLINE    
Iosief Abraha; Isabella Bonacini; Alessandro Montedori
Related Documents :
19542286 - Igr genes and mycobacterium tuberculosis cholesterol metabolism.
12441796 - Virion-associated cholesterol is critical for the maintenance of hiv-1 structure and in...
6428456 - Thermodynamics of lipid-protein association. enthalphy of association of apolipoprotein...
25294406 - Maternal diet during early childhood, but not pregnancy, predicts diet quality and frui...
21337956 - Effect of nandrolone decanoate on the development of three species of chrysomya (dipter...
19577296 - Carcinogenic effect of arsenate in c57bl/6j/han mice and its modulation by different di...
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Lancet     Volume:  367     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-13     Completed Date:  2006-02-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  469; author reply 470-1     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Disease / etiology,  prevention & control*
Diabetes Complications
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects,  therapeutic use*
Hyperlipidemias / drug therapy*
Women's Health
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comment On:
Lancet. 2005 Oct 8;366(9493):1267-78   [PMID:  16214597 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Back pain emergencies.
Next Document:  Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct hum...